Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Santos Esteban
Amgen | 4: Statement of changes in beneficial ownership of securities-Officer REESE DAVID M
Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144
Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Miller Derek
Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144
Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144
Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144
Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144
Amgen | 10-K: FY2024 Annual Report
Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Gordon Murdo
Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144
Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Graham Jonathan P
Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144
Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Grygiel Nancy A.
Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144
Amgen | 8-K: AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Graham Jonathan P
Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Bradway Robert A
Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Khosla Rachna
Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Busch Matthew C.